Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.
about
Stronger is not always better: could a bodybuilding dietary supplement lead to ALS?Glial cells as intrinsic components of non-cell-autonomous neurodegenerative diseaseAndrogen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in modelPrimary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammationFrom animal models to human disease: a genetic approach for personalized medicine in ALSNeuroinflammation in motor neuron diseaseMicroglia centered pathogenesis in ALS: insights in cell interconnectivityTherapeutic neuroprotective agents for amyotrophic lateral sclerosisMicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosisThe omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosisDoes neuroinflammation fan the flame in neurodegenerative diseases?Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.The Cu, Zn Superoxide Dismutase: Not Only a Dismutase EnzymeThe complex molecular biology of amyotrophic lateral sclerosis (ALS)The ubiquitin proteasome system in glia and its role in neurodegenerative diseasesA mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration.S-nitrosothiol depletion in amyotrophic lateral sclerosis.Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.An in vitro screening cascade to identify neuroprotective antioxidants in ALSNeuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis.Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1.Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic miceMuscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophyComplex genetics of amyotrophic lateral sclerosis.Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.Differential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 miceD-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosisFocal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS.Screening for inhibitors of the SOD1 gene promoter: pyrimethamine does not reduce SOD1 levels in cell and animal modelsVirus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.Phenotypic effects of familial amyotrophic lateral sclerosis mutant Sod alleles in transgenic Drosophila.Genetic rodent models of amyotrophic lateral sclerosisGlial cell inclusions and the pathogenesis of neurodegenerative diseasesProgress in therapy development for amyotrophic lateral sclerosisAstroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS)Motor neuron trophic factors: therapeutic use in ALS?Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis
P2860
Q24607879-27E3E48D-BA18-4B57-B882-8A93DA2E21CCQ24621854-C5EA93A5-9C31-4B46-AD9D-09F5F48B798FQ24673304-6380D69B-A031-4BAD-9D77-12AC1FECE6BCQ25256714-8E431E1F-53B8-4957-A408-E3B503296DB6Q26741250-FB3CD57A-5377-4FAA-AD41-CE3E6D7811D0Q26776339-2B138036-2E7D-4C67-8EE8-E03BB7F926B7Q27009559-0DF4F5DB-66FD-45A1-8142-E956A672AB28Q27015029-E40779E9-BB56-48B6-A3F2-66F88096AB3AQ27321524-D6E3FA96-8B39-42A6-8C3C-3F264BBD98ACQ27324363-B3641F21-D0A1-47AC-BE74-E57AE671C037Q27498993-B6A05293-2A7B-44E6-8CBD-B1FA1569FFA7Q27687333-285F0B26-DBD0-4D2E-B987-C6B137130A3BQ28076049-21E31807-F945-4410-84B3-905C77A601D8Q28263899-5C74CEAA-74A1-491B-B8C2-2D3665455220Q28391948-8A707F5D-F7CB-4A49-A5D0-51E3FDC0FE8BQ28585283-DCA17F09-438D-4063-BD9B-154F939C886FQ30446260-24F468CE-4DDC-4842-9ACB-11D5B5E492C1Q30542282-A853847A-AB20-4FBD-B986-1E7F7023F80EQ33445432-3EFAEEF8-BA30-4340-9259-84C139038492Q33703773-2D301715-8118-42E9-BF9B-9B1011980E4CQ33714159-E4A8900B-C8DD-48A2-856D-807B521D5329Q33723622-4711100D-8327-45B3-86A0-F468CB502649Q33832905-051F80CE-AFBC-4FB1-B3A8-A33593D8BDBEQ33894661-50FC226D-4438-4B95-B51C-B9ED9C91E39BQ33910597-47489C36-FB6E-410A-9942-9847222B84D2Q33919781-ECCA7476-190F-485B-8115-E0CD1B7E424AQ33975101-29FACC17-63E0-4B78-ACAB-9C52FFF2456AQ34006224-11F8B8D0-213F-4A98-936B-524DD29AF8F9Q34010341-7E33F5CC-F799-4783-B366-F28EA457B771Q34052467-D30A77D7-9616-4B22-8491-CDE7A234E7F9Q34092226-9FF4DABB-71CC-4A81-8192-3ECF6131188BQ34234969-C2D6F399-4AD1-46FC-86A0-A6F57CA12F76Q34313224-99A61333-5DF4-4105-9DB7-42EF6559B6CFQ34467971-D84DA552-74E9-4BEC-8859-1B4D1365B1D5Q34497123-4467E636-D2FC-4DD4-AAF8-19B0947DBFDBQ34538330-FC270D13-96B1-460E-8EE2-DF1D9E15E442Q34640800-CD786921-6AFE-48BD-B643-78571515A0B9Q34698706-BB46F73A-14E4-46B1-8798-ED6C452EA508Q35027903-B68C2EC9-56F4-4DA1-AE7F-1990E4E9FBD1Q35094527-3EBE2F2D-18D8-4BBD-9983-F468249E56C8
P2860
Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Neuron-specific expression of ...... not lead to motor impairment.
@en
Neuron-specific expression of ...... not lead to motor impairment.
@nl
type
label
Neuron-specific expression of ...... not lead to motor impairment.
@en
Neuron-specific expression of ...... not lead to motor impairment.
@nl
prefLabel
Neuron-specific expression of ...... not lead to motor impairment.
@en
Neuron-specific expression of ...... not lead to motor impairment.
@nl
P2093
P1476
Neuron-specific expression of ...... s not lead to motor impairment
@en
P2093
A Pramatarova
G A Rouleau
J Laganière
K Brisebois
P304
P356
10.1523/JNEUROSCI.21-10-03369.2001
P407
P577
2001-05-01T00:00:00Z